Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Acta Haematol. 2019;141(1):23-27. doi: 10.1159/000494427. Epub 2018 Nov 21.
Myeloproliferative neoplasms (MPNs) are clonal disorders divided into Philadelphia (Ph) chromosome-positive chronic myeloid leukemia (CML) or Ph chromosome-negative MPNs. Co-occurrence of these disease entities is very rare and typically involves presence of common p190 or p210 BCR/ABL fusion transcript (responsible for CML) along with JAK2V617F mutation (most common driver mutation in Ph-negative MPNs). Because of the rarity of such cases, it is not clear if the outcomes are any different in these patients. In this article, we report a unique patient with polycythemia vera driven by a rare complex in-frame deletion-insertion mutation in JAK2 exon 12, and CML driven by uncommon p210 e14a3 (b3a3) BCR/ABL fusion transcript. We describe clinical and laboratory features, bone marrow pathology, treatment, and overall outcome.
骨髓增殖性肿瘤(MPN)是一组克隆性疾病,分为费城染色体阳性慢性髓系白血病(CML)或费城染色体阴性 MPN。这些疾病实体的同时发生非常罕见,通常涉及共同存在 p190 或 p210 BCR/ABL 融合转录本(负责 CML)以及 JAK2V617F 突变(Ph 阴性 MPN 中最常见的驱动突变)。由于此类病例罕见,尚不清楚这些患者的结局是否有差异。在本文中,我们报告了一例独特的患者,其真性红细胞增多症由 JAK2 外显子 12 中罕见的复杂框内缺失-插入突变驱动,CML 则由罕见的 p210 e14a3(b3a3)BCR/ABL 融合转录本驱动。我们描述了其临床和实验室特征、骨髓病理学、治疗和总体结局。